328 Batf3 dendritic cells and 4–1BB/4–1BB ligand axis are required at the effector phase within the tumor microenvironment for anti-PD-L1 efficacy

by Thomas Gajewski, Brendan Horton, Ken Hatogai, Andrea Ziblat, Emily Higgs
Published 2021-11-01

183 Overcoming immunotherapy resistance in T cell-inflamed lung cancer

by Brendan Horton, Duncan Morgan, Noor Momin, Vidit Bhandarkar, Dane Wittrup, Chris Love
Published 2020-11-01

664 Pulmonary priming of tumor-reactive CD8+ T cells by DC1 is impaired by regulatory T cells

by Stefani Spranger, Brendan Horton, Maria Zagorulya, Duncan Morgan, Elen Torres-Mejia, Leon Yim
Published 2021-11-01

Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies

by Fan Zhang, Brendan Horton, Marco Ruella, Vivek Verma, Abigail Overacre-Delgoffe, Kristin G Anderson, Jennifer L Guerriero, Teresa S Kim, David A Braun, Aitziber Buqué, Sarah B Gitto, Bridget P Keenan, Todd A Triplett, Omkara Veeranki
Published 2023-06-01